|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4196 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| A61K 31/423 | (2006.01) | ||
| A61K 31/565 | (2013.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61K 31/4196 | (2013.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61K 31/506 | (2013.01) | ||
| A61K 31/565 | (2006.01) | ||
| A61K 31/519 | (2013.01) | ||
| A61K 31/7064 | (2006.01) | ||
| A61K 31/423 | (2013.01) | ||
| A61K 31/18 | (2006.01) | ||
| A61K 31/7064 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/18 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Patento numeris | 4181920 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 21749550.6 |
| Europos patento paraiškos padavimo data | 2021-07-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2023-05-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2025-09-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2021/069787 |
| Data | 2021-07-15 |
| (87) | Numeris | WO 2022/013369 |
| Data | 2022-01-20 |
| (30) | Numeris | Data | Šalis |
| 202063052215 P | 2020-07-15 | US | |
| 202163211044 P | 2021-06-16 | US |
| (72) |
STUPPLE, Paul Anthony , AU
MAZUREK, Anthony , US
ARNDT, Kim Timothy , US
CHEN, Lei , US
FOLLETTIE, Maximillian Todd , US
FRUHLING, David Scott , US
KUNG, Pei-Pei , US
ZHONG, Wenyan , US
TEDESCHI, Philip Michael , US
|
| (73) |
Pfizer Inc. ,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
CTXT PTY LTD , 305 Grattan Street Parkville, Melbourne, VIC 3000, AU |
| (54) | KAT6 INHIBITOR AND COMBINATIONS FOR BREAST CANCER TREATMENT |
| KAT6 INHIBITOR AND COMBINATIONS FOR BREAST CANCER TREATMENT |